Piedmont Investment Advisors’s Emergent Biosolutions EBS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q2 | – | Sell |
-11,423
| Closed | -$577K | – | 1024 |
|
|
2019
Q1 | $577K | Buy |
11,423
+642
| +6% | +$32.4K | 0.02% | 461 |
|
|
2018
Q4 | $639K | Buy |
10,781
+531
| +5% | +$31.5K | 0.03% | 376 |
|
|
2018
Q3 | $675K | Buy |
10,250
+1,748
| +21% | +$115K | 0.03% | 402 |
|
|
2018
Q2 | $429K | Buy |
8,502
+904
| +12% | +$45.6K | 0.02% | 497 |
|
|
2018
Q1 | $400K | Buy |
7,598
+264
| +4% | +$13.9K | 0.01% | 474 |
|
|
2017
Q4 | $341K | Sell |
7,334
-397
| -5% | -$18.5K | 0.01% | 519 |
|
|
2017
Q3 | $313K | Buy |
7,731
+204
| +3% | +$8.26K | 0.01% | 555 |
|
|
2017
Q2 | $255K | Buy |
+7,527
| New | +$255K | 0.01% | 618 |
|